Completed
Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)
NCT01506414
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Qilu Hospital, Shandong University Jinan, Shandong, China